Status:
COMPLETED
Italian Validation of the LARS Score
Lead Sponsor:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Conditions:
Rectal Cancer
Eligibility:
All Genders
18+ years
Brief Summary
BACKGROUND and RATIONALE Colorectal cancer, with 49,000 new diagnoses expected in 2019 (27,000 in men and 22,000 in women) represents, in Italy, the third neoplasm in men (14%) and the second in women...
Detailed Description
1. BACKGROUND and RATIONALE Colorectal cancer, with 49,000 new diagnoses expected in 2019 (27,000 in men and 22,000 in women) represents, in Italy, the third neoplasm in men (14%) and the second in wo...
Eligibility Criteria
Inclusion
- rectal neoplasia (between 0 and 15 cm from the anal verge);
- anterior rectal resection surgery with total or partial mesorectal excision (TME or PME) in the period January 2000 - April 2018;
- if a stoma had been created, intestinal continuity must have been restored for at least 24 months (by April 2018);
Exclusion
- dementia;
- metastatic or recurrent disease;
- other intestinal diseases (including Crohn's disease, ulcerative colitis);
- patients with a stoma or with intestinal continuity restored for less than 24 months;
- patients with problems of understanding the Italian language.
Key Trial Info
Start Date :
October 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 10 2020
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04406311
Start Date
October 1 2020
End Date
December 10 2020
Last Update
December 14 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fondazione Policlinico universitario Agostino Gemelli
Roma, RM, Italy, 00168